-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody for Robust Immunoflu
2026-06-26
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody delivers high-sensitivity fluorescent detection for rabbit IgG-based immunoassays, streamlining workflows in neuroinflammation and gut–brain axis research. Its signal amplification and low background make it a top choice for reproducible IHC and ICC studies.
-
Quercetin: Multi-Pathway Ferroptosis Modulation in Cancer Re
2026-06-26
Explore how Quercetin, a potent PI3K inhibitor, uniquely modulates ferroptosis and mitochondrial apoptosis, offering translational advantages for advanced cancer research protocols. This article delivers a mechanistic deep-dive and practical workflow guidance beyond conventional PI3K inhibition.
-
Polyphyllin H Targets Cholesterol to Reverse Paclitaxel Resi
2026-06-25
The referenced study demonstrates that Polyphyllin H reverses paclitaxel resistance in breast cancer by binding membrane cholesterol and disrupting ABC transporter function. This multi-target strategy offers a promising alternative to single-transporter inhibition, with broad implications for overcoming multidrug resistance.
-
Entinostat (MS-275): Advanced HDAC Inhibition for Cancer & R
2026-06-25
Entinostat (MS-275) offers researchers a potent, selective HDAC1/3 inhibitor for rigorous cancer cell proliferation inhibition and apoptosis studies, with emerging applications in tissue regeneration. This article delivers stepwise protocols, troubleshooting advice, and a critical review of cross-disciplinary findings to help labs maximize the translational impact of Entinostat.
-
AZD3463: Potent ALK/IGF1R Inhibitor for Neuroblastoma Resear
2026-06-24
AZD3463 is a highly selective ALK/IGF1R inhibitor that demonstrates strong in vitro and in vivo efficacy against neuroblastoma, including cases with ALK activating mutations. Its ability to block PI3K/AKT/mTOR signaling and enhance chemotherapy responses makes it a crucial tool for translational cancer research. Sourced from APExBIO, AZD3463's stability and performance parameters are well-documented for robust bench workflows.
-
TCAIM-Mediated OGDH Proteolysis Regulates Mitochondrial Meta
2026-06-23
This study identifies TCAIM, a novel mitochondrial DNAJ co-chaperone, as a selective regulator of the α-ketoglutarate dehydrogenase (OGDH) complex via proteolytic degradation. The findings reveal a new post-translational mechanism controlling mitochondrial metabolism, with implications for metabolic regulation and disease.
-
STING Agonist-1 in Immunology: Experimental Workflows & Opti
2026-06-23
STING agonist-1 offers unmatched precision for dissecting innate immune activation, B cell signaling, and TLS formation in tumor microenvironments. This guide translates the latest mechanistic insights into actionable protocols, troubleshooting tips, and advanced applications for cancer immunology and inflammation research.
-
Dorsomorphin 2HCl: Precision Inhibition of AMPK and BMP Path
2026-06-22
Explore how Dorsomorphin 2HCl, a potent AMPK inhibitor, enables targeted dissection of metabolic and signaling networks. Uncover unique mechanistic insights, new applications, and guidance for advanced research workflows.
-
Flumequine: Enabling Precision in DNA Topoisomerase II Resea
2026-06-22
Explore how Flumequine, a rigorously validated DNA topoisomerase II inhibitor, provides translational researchers with mechanistic clarity, experimental reliability, and strategic guidance for advanced cancer and DNA repair studies. This thought-leadership article synthesizes recent in vitro insights, benchmarking parameters, and workflow innovations to empower next-generation drug response research.
-
Early Life Adversity Impairs Visual Defense via Oxytocin Pat
2026-06-21
Tan et al. (2026) demonstrate that social deprivation during a critical postnatal period leads to impaired visually evoked innate defensive behaviors in mice, mediated by deficits in oxytocin signaling within the superior colliculus. This work advances understanding of how early life adversity shapes neural fear circuits, highlighting oxytocin as a potential therapeutic target.
-
Poly (I:C): Synthetic Double-Stranded RNA Analog for Immune
2026-06-20
Poly (I:C), a synthetic double-stranded RNA analog, propels innate immune research by precisely activating TLR3 and driving dendritic cell maturation. Its unique solubility and potency make it indispensable for reliable interferon induction and advanced in vitro immune modeling.
-
Competitive CD40–STING–TRAF2 Binding Drives B Cell Activatio
2026-06-19
This study delineates how competitive interactions between CD40 and STING for TRAF2 binding regulate IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings reveal mechanistic links between TLS, STING pathway activation, and antitumor B cell responses, highlighting new research and biomarker opportunities in cancer immunology.
-
Small Molecules Enable Efficient Generation of Pancreatic Du
2026-06-19
Liao et al. present a protocol leveraging a small molecule cocktail to generate pancreatic ductal organoids with high initiation efficiency and long-term expansion potential. This work provides a robust, reproducible model for studying pancreatic diseases and drug screening, overcoming previous limitations in organoid heterogeneity and scalability.
-
Early Life Adversity Disrupts Innate Defensive Behaviors via
2026-06-18
This study reveals that early life adversity (ELA) impairs visually evoked innate defensive behaviors in mice by disrupting oxytocin signaling in the superior colliculus. The mechanistic findings underscore a critical developmental link between early stress, altered oxytocin pathways, and long-term deficits in fear processing, offering new targets for intervention.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Optimizing Immunofl
2026-06-18
Unlock sensitive and reproducible detection in immunofluorescence, IHC, and ICC workflows with the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody. This guide delivers practical protocol enhancements, troubleshooting strategies, and cross-study insights for maximizing signal and minimizing background in fluorescence-based assays.